Seyed Alamian MD in Oklahoma City, Oklahoma

Home Oklahoma Oklahoma City

Seyed Alamian MD has Pulmonary Disease as his primary medical specialty. Their primary office is: 13313 N Meridian Ave C in Oklahoma City, Oklahoma.

They're a part of the: Mercy Clinic Oklahoma Communities medical group which has around 488 members. You can call their office at 405-254-9676 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1987 (around 37 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Seyed M Alamian MD Office Phone and Directions

Seyed Alamian MD
Mercy Clinic Oklahoma Communities
13313 N Meridian Ave C
Oklahoma City, Oklahoma 73120
405-254-9676

Patient Ratings
Please rate your experience with Seyed Alamian MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 405-254-9676

Enter a starting address:

Healthcare Info for Seyed Alamian MD

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS), INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1987
The Primary Medical Specialty for Seyed Alamian MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 37
PAC (PECOS ID)#: 8921900101
NPI #: 1427067628
NPI Created On: 08/05/2006
NPI Last Updated Listed as: 04/24/2017
Primary Taxonomy Code: 207RP1001X
License Number:
22230
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Persian, Spanish.

Services and Procedures include:

Emergent insertion of breathing tube into windpipe cartilage using an endoscope
Measurement and graphic recording of total and timed exhaled air capacity
Determination of lung volumes using plethysmography
Measurement of lung diffusing capacity
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Hospital discharge day management, more than 30 minutes
Critical care delivery critically ill or injured patient, first 30-74 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801740097

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $30

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801741895

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802891487

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803188621

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843551695

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Immunology

Name of Drug #1: DUPIXENT

Open Associated Drug #1: 0024-5914-01

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;G2777156;CONCUR;10276201

Record ID:: 848153705

Being Disputed:: No

Product Related: Yes

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832910657

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR;METABOLIC DISEASE

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0893-21

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848348965

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: INFECTIOUS DISEASE

Name of Drug #1: DIFICID

Open Associated Drug #1: 52015-080-01

Drug or Biological: Drug

Product Category #2: INFECTIOUS DISEASE

Name Of Drug #2:: ZERBAXA

Associated Drug #2: 67919-030-01

Drug or Biological #3:: Drug

Product Category #3: INFECTIOUS DISEASE

Name of Drug: RECARBRIO

Name Of Drug #3: 0006-3856-02

Drug or Biological: Biological

Product Category #4: INFECTIOUS DISEASE

Name of Drug #4: ZINPLAVA

Associated Drug #4: 0006-3025-00

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848520215

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: INFECTIOUS DISEASE

Name of Drug #1: DIFICID

Open Associated Drug #1: 52015-080-01

Drug or Biological: Drug

Product Category #2: INFECTIOUS DISEASE

Name Of Drug #2:: RECARBRIO

Associated Drug #2: 0006-3856-02

Drug or Biological #3:: Biological

Product Category #3: INFECTIOUS DISEASE

Name of Drug: ZINPLAVA

Name Of Drug #3: 0006-3025-00

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848613997

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: BELSOMRA

Open Associated Drug #1: 0006-0335-30

Pulmonary Disease Professionals in Oklahoma City

1.
Stacey Foshee

3100 Sw 89th St
Oklahoma-city, OK

2.
Gregory Mckinnis MD

608 Nw 9th St
Oklahoma-city, OK

3.
Gregory Mckinnis MD

1000 N Lee Ave
Oklahoma-city, OK
Healthfirst Physicians Management Services, Inc.

4.
Gregory Mckinnis MD

3418 Nw 135th St
Oklahoma-city, OK
Nextgen Sleep Llc

5.
Kevin Oneal

5501 N Portland
Oklahoma-city, OK
Integris Ambulatory Care Corporation

6.
Kevin Oneal

3366 Nw Expressway
Oklahoma-city, OK
Integris Ambulatory Care Corporation

Providers in Mercy Clinic Oklahoma Communities

1.John Abbott

4140 W Memorial Rd
Oklahoma City Ok 73120-8365
Mercy Clinic Oklahoma Communities
General Surgery

2.Jean Abed

4205 Mcauley Blvd
Oklahoma City Ok 73120-9309
Mercy Clinic Oklahoma Communities
Gastroenterology

3.David Abernethy

4300 Mcauley Blvd
Oklahoma City Ok 73120-8302
Mercy Clinic Oklahoma Communities
Hospitalist

4.David Abernethy

4300 W Memorial Rd
Oklahoma City Ok 73120-8304
Mercy Clinic Oklahoma Communities
Hospitalist

5.Ghaith Al-qudah

435 N Monte Vista St
Ada Ok 74820-4676
Mercy Clinic Oklahoma Communities
General Surgery

6.Junaid Alam

430 N Monte Vista St
Ada Ok 74820-4610
Mercy Clinic Oklahoma Communities
Internal Medicine

View all 488 members of Mercy Clinic Oklahoma Communities medical group